Conference Presentation, Webinar, Fireside Chat, Interview
How COVID-19 Tests Will Help Reopen America - Conference Call Series
Rhode Island Testing Status and Strategy
- As of the call, Rhode Island had conducted over 12,000 positive tests and 500 fatalities, having tested nearly 12% of the state's population.
- Governor Gina Raimondo emphasizes an "SOS" (Symptomatics, Outbreaks, Surveillance) testing model designed to stay ahead of viral transmission.
- Symptomatics: Goal to provide testing within one day and results within the following 24 hours.
- Outbreaks: Commitment to deploy mobile teams to outbreak sites within four hours for immediate mass testing.
- Surveillance: Implementation of constant population surveillance, particularly in dense urban and poor communities where outbreaks are occurring.
- Governor Raimondo prioritizes equity in testing access, ensuring availability regardless of income, race, gender, immigration status, or zip code.
- By July, the state aims to increase daily testing capacity from 3,000 to 10,000; by the start of the school year, capacity targets 15,000 to 20,000 tests per day.
- All residents and workers in Rhode Island nursing homes were tested as of the previous Monday, with regular re-testing scheduled.
Phased Economic Reopening in Rhode Island
- Rhode Island is in Phase One of reopening, initiated May 8th, which allows social gatherings of up to five people and the resumption of manufacturing, construction, and retail with restrictions.
- Outdoor dining was launched on the day of the call, noting high compliance with mask-wearing and social distancing.
- Phase Two is projected to begin in early June, featuring relaxation for in-room dining, increased gathering limits, and the reopening of hairdressers and barbers.
- Phase Three is anticipated approximately one month after Phase Two to enable further economic activity.
- Governor Raimondo highlights that the reopening strategy specifically targets low-wage workers in sectors like retail, food service, and tourism who cannot work remotely.
- Rhode Island is in Phase One of reopening, initiated May 8th, which allows social gatherings of up to five people and the resumption of manufacturing, construction, and retail with restrictions.
LabCorp National Capacity and Capabilities
- LabCorp has performed nearly 2 million PCR tests to date and aims to reach 150,000 PCR tests per day by mid-June (currently at 75,000/day).
- The company has conducted over 500,000 antibody tests and plans to scale capacity to 300,000 tests per day by mid-June (currently over 100,000/day).
- CEO Adam Schechter notes the total U.S. commercial testing volume reached approximately 11 million tests within six to eight weeks of commercial lab involvement.
- LabCorp has deployed its PIXL at-home test kit, allowing overnight shipping of the test and return sample for processing with results in one to two days.
Testing Accuracy and Limitations
- LabCorp's PCR tests are described as highly accurate with 1-2 day turnaround times for results.
- LabCorp's antibody tests show specificity rates between 99% and 99.8% for COVID-19.
- Schechter cautions that while antibodies indicate past infection, the duration and certainty of immunity against future infection remain scientifically unproven.
- The company advises continued adherence to social distancing and hygiene protocols even for individuals with antibodies, as herd immunity is not yet a reliable strategy.
- Schechter urges consumers to verify that testing providers utilize tests with FDA Emergency Use Authorizations (EUAs) to ensure accuracy.
Forward-Looking Statements and Concerns
- Governor Raimondo expresses concern regarding non-COVID healthcare needs, citing instances of cancer patients delaying treatment due to fear of exposure.
- Both speakers warn against complacency during the summer months, predicting potential risks from a combined flu and coronavirus season in the fall.
- Governor Raimondo plans for in-person school reopening in the fall, contingent on achieving sufficient testing capacity and discipline regarding mask-wearing and symptom monitoring.
- Schechter anticipates rapid development of vaccines and treatments, crediting unprecedented collaboration between biotech firms and regulators like the FDA.
- The speakers identify contact tracing systems (supported by partners like Salesforce and Infosys) as critical infrastructure for building public confidence to re-enter the economy.